Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function

Clinical Biochemistry

Volumn 49, Issue 15, 2016, Pages 1140-1143

  El Khoury, Joe M ^a   Bunch, Dustin R ^b   Hu, Bo ^b   Payto, Drew ^b   Reineks, Edmunds Z ^b   Wang, Sihe ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cystatin c; eGFR; Glomerular filtration rate; Kidney function; Symmetric dimethylarginine

Indexed keywords

6 N,N' DIMETHYLARGININE; CREATININE; CYSTATIN C; IOTALAMATE SODIUM; ARGININE; BIOLOGICAL MARKER;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MALE; MATHEMATICAL MODEL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL CLEARANCE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; BLOOD; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION TEST; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; AGED; ARGININE; BIOMARKERS; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84992146535     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.07.009     Document Type: Article

References (19)

1. [1] Coresh, J., Selvin, E., Stevens, L.A., Manzi, J., Kusek, J.W., Eggers, P., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007), 2038–2047.
2. [2] Snyder, J.J., Foley, R.N., Collins, A.J., Prevalence of CKD in the United States: a sensitivity analysis using the national health and nutrition examination survey (NHANES) 1999–2004. Am. J. Kidney Dis. 53 (2009), 218–228.
3. [3] Stevens, L.A., Coresh, J., Greene, T., Levey, A.S., Assessing kidney function–measured and estimated glomerular filtration rate. N. Engl. J. Med. 354 (2006), 2473–2483.
4. [4] Levey, A.S., Inker, L.A., Coresh, J., GFR estimation: from physiology to public health. Am. J. Kidney Dis. 63 (2014), 820–834.
5. [5] Inker, L.A., Schmid, C.H., Tighiouart, H., Eckfeldt, J.H., Feldman, H.I., Greene, T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367 (2012), 20–29.
6. [6] Rule, A.D., Glassock, R.J., GFR estimating equations: getting closer to the truth?. Clin. J. Am. Soc. Nephrol. 8 (2013), 1414–1420.
7. [7] Martens-Lobenhoffer, J., Bode-Boger, S.M., Amino acid N-acetylation: metabolic elimination of symmetric dimethylarginine as symmetric N(alpha)-acetyldimethylarginine, determined in human plasma and urine by LC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 975 (2015), 59–64.
8. [8] Schwedhelm, E., Boger, R.H., The role of asymmetric and symmetric dimethylarginines in renal disease. Nat. Rev. Nephrol. 7 (2011), 275–285.
9. [9] Hokamp, J.A., Nabity, M.B., Renal biomarkers in domestic species. Vet. Clin. Pathol. 45 (2016), 28–56.
10. [10] El-Khoury, J.M., Bunch, D.R., Reineks, E., Jackson, R., Steinle, R., Wang, S., A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges. Anal. Bioanal. Chem. 402 (2012), 771–779.
11. [11] Kielstein, J.T., Boger, R.H., Bode-Boger, S.M., Frolich, J.C., Haller, H., Ritz, E., et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J. Am. Soc. Nephrol. 13 (2002), 170–176.
12. [12] Fliser, D., Kronenberg, F., Kielstein, J.T., Morath, C., Bode-Boger, S.M., Haller, H., et al. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J. Am. Soc. Nephrol. 16 (2005), 2456–2461.
13. [13] Tarnow, L., Hovind, P., Teerlink, T., Stehouwer, C.D., Parving, H.H., Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 27 (2004), 765–769.
14. [14] Tutarel, O., Denecke, A., Bode-Boger, S.M., Martens-Lobenhoffer, J., Schieffer, B., Westhoff-Bleck, M., et al. Symmetrical dimethylarginine outperforms CKD-EPI and MDRD-derived eGFR for the assessment of renal function in patients with adult congenital heart disease. Kidney Blood Press. Res. 34 (2011), 41–45.
15. [15] Atzler, D., Schwedhelm, E., Nauck, M., Ittermann, T., Boger, R.H., Friedrich, N., Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania. Clin. Chem. Lab. Med. 52 (2014), 1835–1842.
16. [16] Glyn, M.C., Anderssohn, M., Luneburg, N., Van Rooyen, J.M., Schutte, R., Huisman, H.W., et al. Ethnicity-specific differences in L-arginine status in South African men. J. Hum. Hypertens. 26 (2012), 737–743.
17. [17] Blackwell, S., O'Reilly, D.S., Talwar, D., Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur. J. Clin. Investig. 37 (2007), 364–371.
18. [18] Reinhard, M., Erlandsen, E.J., Randers, E., Biological variation of cystatin C and creatinine. Scand. J. Clin. Lab. Invest. 69 (2009), 831–836.
19. [19] Kielstein, J.T., Veldink, H., Martens-Lobenhoffer, J., Haller, H., Burg, M., Lorenzen, J.M., et al. SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol. Dial. Transplant. 26 (2011), 324–328.